First Bancorp’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
First Bancorp's IBB Position: Q2 2022 in Review
First Bancorp sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 1,645 shares — an estimated $215K sold.
First Bancorp first reported a position in IBB in Q1 2021 and held it in 4 quarters. The position peaked at $242K in Q3 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.
- First Bancorp reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
- First Bancorp sold 1,645 iShares Biotechnology ETF shares in Q2 2022, an estimated $215K.
- First Bancorp first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 4 quarters.
- First Bancorp's iShares Biotechnology ETF position peaked at $242K in Q3 2021.
- 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.
Based on First Bancorp's 13F filing for Q2 2022, filed 14 Jul 2022.